Literature DB >> 215705

Pseudotypes of vesicular stomatitis virus and Pichinde virus.

S Sengupta, W E Rawls.   

Abstract

Super-infection of Pichinde virus-infected cells with vesicular stomatitis virus (VSV) resulted in the production of pseudotype virus which was not neutralized by antiserum to VSV but which was neutralized by antiserum to Pichinde virus. Analysis of pseudotype virus production in relation to the kinetics of replication of Pichinde virus demonstrated that pseudotype virus production occurred when super-infection with VSV was initiated 8 h or more after infecting the cells with Pichinde virus. The quantities of pseudotype virus produced correlated with the quantities of Pichinde virus antigen detected on the surface of the cells both during acute infection and in cells chronically infected with Pichinde virus. The observations indicate that pseudotype of VSV and Pichinde virus are readily formed and that the formation of pseudotype virus may be used to examine the Pichinde virus antigens expressed on the surface of infected cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 215705     DOI: 10.1099/0022-1317-42-1-141

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Synthesis of virus-specific polypeptides and genomic RNA during the replicative cycle of Pichinde virus.

Authors:  K Dimock; D G Harnish; G Sisson; W C Leung; W E Rawls
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

2.  Evaluation of plaque size reduction as a method for the detection of Pichinde virus antibody.

Authors:  A C Chanas; P R Young; D S Ellis; G Mann; S Stamford; C R Howard
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses.

Authors:  Rachel B Brouillette; Elisabeth K Phillips; Natarajan Ayithan; Wendy Maury
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.